newsfilter
← Latest News
ACCESS Newswire·

MIRA Pharmaceuticals Announces Ketamir-2 Outperforms Current FDA-Approved Neuropathic Pain Treatments, Gabapentin and Pregabalin, in Preclinical Study

MIAMI, FL / ACCESSWIRE / October 21, 2024 / MIRA Pharmaceuticals, Inc. , a leading pre-clinical-stage pharmaceutical development company, is excited to announce that its novel oral ketamine analog,